What is the Transparency Council going to do on April 4?
The agenda is:
Preparation of positions on drug evaluation:
Buccolam (midazolamum) in the indication: treatment of prolonged acute seizures in infants, toddlers, children and adolescents (3 months to 18 years),
Jorveza (b...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
